Applied DNA Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

• Applied DNA Sciences Inc APDN.OQ reported a quarterly adjusted loss of $15.35​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-265.50. The lone analyst forecast for the quarter was for a loss of $3.00 per share.

• Revenue rose 5.8% to $983.37 thousand from a year ago; analysts expected $1.19 million.

• Applied DNA Sciences Inc shares had fallen by 51.2% this quarter and lost 92.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 78.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

This summary was machine generated from LSEG data May 16 at 08:09 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)